|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.53 USD | -0.28% |
|
+8.68% | +18.32% |
| 06-30 | FDA clears Orca's blood cancer therapy to reduce stem cell transplant complications | RE |
| 06-29 | Incyte Corporation(NasdaqGS:INCY) dropped from Russell Midcap Growth Benchmark | CI |
| Market Cap | 23.35B 20.41B 18.76B 17.48B 33.16B 2,223B 33.66B 225B 87.54B 1,093B 87.63B 85.75B 3,765B | P/E 2026 * |
17x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 18.33B 16.02B 14.72B 13.72B 26.03B 1,745B 26.43B 177B 68.72B 858B 68.79B 67.32B 2,956B | EV / Sales 2026 * |
3.25x | EV / Sales 2027 * | 2.65x |
| Free-Float |
98.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Incyte Corporation
| 1 day | +2.68% | ||
| 1 week | +8.68% | ||
| Current month | +3.09% | ||
| 1 month | +26.69% | ||
| 3 months | +21.82% | ||
| 6 months | +15.22% | ||
| Current year | +18.32% |
| 1 week | 112.8 |  | 118.69 |
| 1 month | 96.09 | | 118.69 |
| Current year | 89.25 | | 118.69 |
| 1 year | 66.85 | | 118.69 |
| 3 years | 50.27 | | 118.69 |
| 5 years | 50.27 | | 118.69 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 25/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 03/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 04/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 25/06/2025 |
| Director/Board Member | 72 | 19/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 19/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-07 | Free | Director | 7,753 | 0.0039% | ||
| 06-07 | Free | Director | 7,753 | 0.0039% | ||
| 06-07 | Free | Director | 7,753 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.28% | +8.68% | +71.42% | +87.73% | 23.35B | |
| +4.73% | +5.50% | +19.45% | -8.94% | 66.56B | |
| -1.93% | +0.54% | +58.86% | +226.84% | 57.64B | |
| +1.07% | +42.10% | +42.10% | +42.10% | 42.24B | |
| +3.45% | +3.54% | -49.20% | -56.09% | 39.09B | |
| -4.05% | +7.01% | +62.26% | -24.13% | 31.91B | |
| -1.99% | +33.49% | +163.41% | -34.35% | 31.65B | |
| +2.87% | +15.37% | +10.72% | +196.62% | 18.92B | |
| -0.13% | +2.79% | +67.55% | +130.16% | 17.17B | |
| -1.53% | +10.76% | +80.22% | +348.78% | 15.12B | |
| Average | +2.96% | +5.85% | +52.68% | +90.87% | 34.37B | |
| Weighted average by Cap. | +2.84% | +4.55% | +46.40% | +68.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.65B 4.94B 4.54B 4.23B 8.02B 538B 8.14B 54.45B 21.17B 264B 21.19B 20.74B 911B | 6.22B 5.44B 4.99B 4.66B 8.83B 592B 8.96B 59.97B 23.31B 291B 23.34B 22.84B 1,003B |
| Net income | 1.44B 1.26B 1.15B 1.08B 2.04B 137B 2.07B 13.86B 5.39B 67.26B 5.39B 5.28B 232B | 1.67B 1.46B 1.34B 1.25B 2.38B 159B 2.41B 16.14B 6.28B 78.34B 6.28B 6.15B 270B |
| Net Debt | -5.02B -4.39B -4.03B -3.76B -7.13B -478B -7.24B -48.41B -18.82B -235B -18.84B -18.43B -809B | -6.87B -6.01B -5.52B -5.15B -9.76B -654B -9.91B -66.3B -25.77B -322B -25.8B -25.25B -1,109B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$116.86 | +2.68% | 2,632,596 |
| 01/07/26 | US$113.81 | +0.40% | 1,711,033 |
| 30/06/26 | US$113.36 | -1.13% | 1,830,643 |
| 29/06/26 | US$114.66 | +0.80% | 1,532,380 |
| 26/06/26 | US$113.75 | +5.78% | 3,795,266 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
